{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:22:37Z","timestamp":1791588157587,"version":"4.3.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Shandong Province Medical and Health Technology Project","award":["202311001247"],"award-info":[{"award-number":["202311001247"]}]},{"name":"Shandong Provincial Third Hospital Research and Cultivation Fund","award":["Q2023003"],"award-info":[{"award-number":["Q2023003"]}]},{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["ZR2020MH321"],"award-info":[{"award-number":["ZR2020MH321"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12029-025-01180-5","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T17:07:15Z","timestamp":1738084035000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Bile-Derived cfDNA of Syncytin-1 and SLC7A11 as a Potential Molecular Marker for Early Diagnosis of Cholangiocarcinoma"],"prefix":"10.1007","volume":"56","author":[{"given":"Jing","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingrong","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewei","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"key":"1180_CR1","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.jhep.2021.12.010","volume":"76","author":"LI Sanchez","year":"2022","unstructured":"Sanchez LI, Lamarca A, Casta LA, et al. Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA registry. J Hepatol. 2022;76:1109\u201321.","journal-title":"J Hepatol"},{"key":"1180_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","volume":"15","author":"SI Ilyas","year":"2018","unstructured":"Ilyas SI, Khan SA, Hallemeier CL, et al. Cholangiocarcinoma - evolving concepts and therapeutic strategies. Nat Rev Clin Oncol. 2018;15:95\u2013111.","journal-title":"Nat Rev Clin Oncol"},{"key":"1180_CR3","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jhep.2023.01.027","volume":"78","author":"M Cadamuro","year":"2023","unstructured":"Cadamuro M, Taee AA, Gonda TA. Advanced endoscopy meets molecular diagnosis of cholangiocarcinoma. J Hepatol. 2023;78:1063\u201372.","journal-title":"J Hepatol"},{"key":"1180_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/HEP.0000000000000437","volume":"79","author":"LH Shu","year":"2024","unstructured":"Shu LH, Li XY, Liu ZL, et al. Bile exosomal miR-182\/183-5p increases cholangiocarcinoma stemness and progression by targeting HPGD and increasing PGE2 generation. Hepatology. 2024;79:307\u201322.","journal-title":"Hepatology"},{"key":"1180_CR5","doi-asserted-by":"publisher","first-page":"117593","DOI":"10.1016\/j.cca.2023.117593","volume":"551","author":"FS Liu","year":"2023","unstructured":"Liu FS, Hao XY, Liu B, et al. Bile liquid biopsy in biliary tract cancer. Clin Chim Acta. 2023;551:117593.","journal-title":"Clin Chim Acta"},{"key":"1180_CR6","doi-asserted-by":"publisher","first-page":"957","DOI":"10.2147\/IJGM.S294392","volume":"14","author":"Y Fu","year":"2021","unstructured":"Fu Y, Zhuang XW, Xia XY, et al. Correlation between promoter hypomethylation and increased expression of syncytin-1 in non-small cell lung cancer. Int J Gen Med. 2021;14:957\u201365.","journal-title":"Int J Gen Med"},{"key":"1180_CR7","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.annonc.2023.02.010","volume":"34","author":"Q Gao","year":"2023","unstructured":"Gao Q, Lin YP, Li BS, et al. Unintrusive multi-cancer detection by circulating cell-free DNA methylation sequencing (THUNDER): development and independent validation studies. Ann Oncol. 2023;34:486\u201395.","journal-title":"Ann Oncol"},{"key":"1180_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.freeradbiomed.2018.01.023","volume":"117","author":"WX Zhong","year":"2018","unstructured":"Zhong WX, Weiss HL, Jayswal RD, et al. Extracellular redox state shift: a novel approach to target prostate cancer invasion. Free Radic Biol Med. 2018;117:99\u2013109.","journal-title":"Free Radic Biol Med"},{"key":"1180_CR9","first-page":"3106","volume":"10","author":"WY Lin","year":"2020","unstructured":"Lin WY, Wang CQ, Liu GP, et al. SLC7A11\/xCT in cancer: biological functions and therapeutic implications. Am J Cancer Res. 2020;10:3106\u201326.","journal-title":"Am J Cancer Res"},{"key":"1180_CR10","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1111\/cas.15531","volume":"113","author":"C Zeng","year":"2022","unstructured":"Zeng C, Lin J, Zhang KT, et al. SHARPIN promotes cell proliferation of cholangiocarcinoma and inhibits ferroptosis via p53\/SLC7A11\/GPX4 signaling. Cancer Sci. 2022;113:3766\u201375.","journal-title":"Cancer Sci"},{"key":"1180_CR11","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1002\/cncr.34715","volume":"129","author":"JF Kearney","year":"2023","unstructured":"Kearney JF, Weighill D, Yeh JJ. Promise of bile circulating tumor DNA in biliary tract cancers. Cancer. 2023;129:1643\u20135.","journal-title":"Cancer"},{"key":"1180_CR12","doi-asserted-by":"publisher","first-page":"1049812","DOI":"10.3389\/fimmu.2022.1049812","volume":"13","author":"YC Li","year":"2022","unstructured":"Li YC, Li KS, Liu ZL, et al. Research progress of bile biomarkers and their immunoregulatory role in biliary tract cancers. Front Immunol. 2022;13:1049812.","journal-title":"Front Immunol"},{"key":"1180_CR13","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1038\/s41388-022-02313-x","volume":"41","author":"ZL Liu","year":"2022","unstructured":"Liu ZL, Liu JL, Chen TL, et al. Wnt-TCF7-SOX9 axis promotes cholangiocarcinoma proliferation and pemigatinib resistance in a FGF7-FGFR2 autocrine pathway. Oncogene. 2022;41:2885\u201396.","journal-title":"Oncogene"},{"key":"1180_CR14","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.3390\/cancers12061644","volume":"12","author":"JM Urman","year":"2020","unstructured":"Urman JM, Herranz JM, Uriarte I, et al. Pilot multi-omic analysis of human bile from benign and malignant biliary strictures: a machine-learning approach. Cancers (Basel). 2020;12:1644.","journal-title":"Cancers (Basel)"},{"key":"1180_CR15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/hep.32624","volume":"77","author":"MJ Deng","year":"2023","unstructured":"Deng MJ, Ran P, Chen LL, et al. Proteogenomic characterization of cholangiocarcinoma. Hepatology. 2023;77:411\u201329.","journal-title":"Hepatology"},{"key":"1180_CR16","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1021\/acs.jproteome.2c00846","volume":"22","author":"XT Qu","year":"2023","unstructured":"Qu XT, He B, Li ZK, et al. Accurate discrimination of benign biliary diseases and cholangiocarcinoma with serum multiomics revealed by high-throughput nanoassisted laser desorption ionization mass spectrometry. J Proteome Res. 2023;22:1855\u201367.","journal-title":"J Proteome Res"},{"key":"1180_CR17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s12957-023-03176-6","volume":"21","author":"SS Ma","year":"2023","unstructured":"Ma SS, Ma Y, Qi FL, et al. HSDL2 knockdown promotes the progression of cholangiocarcinoma by inhibiting ferroptosis through the P53\/SLC7A11 axis. World J Surg Oncol. 2023;21:293.","journal-title":"World J Surg Oncol"},{"key":"1180_CR18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1186\/s13071-023-06075-7","volume":"16","author":"LJ Wen","year":"2023","unstructured":"Wen LJ, Yin JG, Wang YX, et al. csi-miR-96-5p delivered by Clonorchis sinensis extracellular vesicles promotes intrahepatic cholangiocarcinoma proliferation and migration via the ferroptosis-related PTEN\/SLC7A11\/GPX4 axis. Parasit Vectors. 2023;16:465.","journal-title":"Parasit Vectors"},{"key":"1180_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41576-018-0071-5","volume":"20","author":"E Heitzer","year":"2019","unstructured":"Heitzer E, Haque IS, Roberts CES, et al. Current and future perspectives of liquid biopsies in genomics-driven oncology. Nat Rev Genet. 2019;20:71\u201388.","journal-title":"Nat Rev Genet"},{"key":"1180_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s40291-021-00562-2","volume":"26","author":"S Olmedillas-L\u00f3pez","year":"2022","unstructured":"Olmedillas-L\u00f3pez S, Olivera-Salazar R, Garc\u00eda-Arranz M, et al. Current and emerging applications of droplet digital PCR in oncology: an updated review. Mol Diagn Ther. 2022;26:61\u201387.","journal-title":"Mol Diagn Ther"},{"key":"1180_CR21","doi-asserted-by":"publisher","first-page":"999","DOI":"10.3390\/diagnostics11060999","volume":"11","author":"P Wintachai","year":"2021","unstructured":"Wintachai P, Lim JQ, Techasen A, et al. Diagnostic and prognostic value of circulating cell-free DNA for cholangiocarcinoma. Diagnostics (Basel). 2021;11:999.","journal-title":"Diagnostics (Basel)"},{"key":"1180_CR22","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1056\/NEJMra1706174","volume":"379","author":"RB Corcoran","year":"2018","unstructured":"Corcoran RB, Chabner BA. Application of cell-free DNA analysis to cancer treatment. N Engl J Med. 2018;379:1754\u201365.","journal-title":"N Engl J Med"},{"key":"1180_CR23","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1097\/JCMA.0000000000000923","volume":"86","author":"B-S Shyr","year":"2023","unstructured":"Shyr B-S, Chen S-C, Shyr Y-M, et al. Cell-free DNA as a prognostic and predictive biomarker in resectable distal common bile duct cancer. J Chin Med Assoc. 2023;86:835\u201341.","journal-title":"J Chin Med Assoc"},{"key":"1180_CR24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.lungcan.2008.07.012","volume":"64","author":"M Paci","year":"2009","unstructured":"Paci M, Maramotti S, Bellesia E, et al. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer. Lung Cancer. 2009;64:92\u20137.","journal-title":"Lung Cancer"},{"key":"1180_CR25","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41571-020-00457-x","volume":"18","author":"M Ignatiadis","year":"2021","unstructured":"Ignatiadis M, Sledge GW, Jeffrey SS. Liquid biopsy enters the clinic - implementation issues and future challenges. Nat Rev Clin Oncol. 2021;18:297\u2013312.","journal-title":"Nat Rev Clin Oncol"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01180-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-025-01180-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01180-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T17:07:22Z","timestamp":1738084042000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-025-01180-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1180"],"URL":"https:\/\/doi.org\/10.1007\/s12029-025-01180-5","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,28]]},"assertion":[{"value":"18 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Shandong Provincial Third Hospital, Shandong University (No. KYLL-2023084).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}],"article-number":"55"}}